Neuropsychopharmacology

GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia.  45:2207-2218. 2020

Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia.  45:1059-1067. 2020

Regulation of dopamine-dependent transcription and cocaine action by Gadd45b 2020

A longitudinal neurite and free water imaging study in patients with a schizophrenia spectrum disorder.  44:1932-1939. 2019

The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia..  44:1562-1569. 2019

A dose-finding study of oxytocin using neurophysiological measures of social processing.  44:289-294. 2019

Cognitive deficit in methamphetamine users relative to childhood academic performance: Link to cortical thickness.  43:1745-1752. 2018

Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus.  43:1445-1456. 2018

Glutamate in pediatric obsessive-compulsive disorder and response to cognitive-behavioral therapy: Randomized clinical trial.  42:2414-2422. 2017

Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects.  42:1610-1618. 2017

Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder.  42:864-875. 2017

Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease.  41:2171-2177. 2016

Erratum: Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease (Neuropsychopharmacology (2016) 41 (2188) DOI: 10.1038/npp.2016.18).  41:2188. 2016

Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity during Risky Decision Making.  41:695-703. 2016

Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia.  41:896-905. 2016

Influence of early life stress on intra- and extra-amygdaloid causal connectivity.  40:1782-1793. 2015

Corrigenda - Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness (Neuropsychopharmacology Reviews (2014) 39, (65-87) DOI: 10.1038/npp.2013.239).  40:1307. 2015

Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.  39:1020-1030. 2014

N-glycosylation of GABAA receptor subunits is altered in schizophrenia.  39:528-537. 2014

Cigarette exposure, dependence, and craving are related to insula thickness in young adult smokers.  39:1816-1822. 2014

Postmortem brain: An underutilized substrate for studying severe mental illness.  39:65-87. 2014

Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: Relationship to treatment and treatment response.  39:2095-2103. 2014

Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.  38:1910-1920. 2013

Erratum: Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes (Neuropsychopharmacology (2013) 38 (1140) DOI: 10.1038/npp.2013.14).  38:1140. 2013

Regional decoupling of n-acetyl-aspartate and glutamate in schizophrenia.  37:2635-2642. 2012

Yohimbine depresses excitatory transmission in bnst and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.  37:2253-2266. 2012

Activation of the orexin 1 receptor is a critical component of CO 2-mediated anxiety and hypertension but not bradycardia.  37:1911-1922. 2012

Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.  37:896-905. 2012

Gene-centric analysis of serum cotinine levels in African and European American populations.  37:968-974. 2012

Epigenetic treatments for cognitive impairments.  37:247-260. 2012

Review of pharmacological treatment in mood disorders and future directions for drug development.  37:77-101. 2012

Functional biomarkers of depression: Diagnosis, treatment, and pathophysiology.  36:2375-2394. 2011

Is CREB the angry bird that releases memory in alzheimer's.  36:2153-2154. 2011

Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia.  36:1779-1780. 2011

Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the clockδ19 mouse model of mania.  36:1478-1488. 2011

Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals.  36:950-959. 2011

Epigenetic modifications in neurons are essential for formation and storage of behavioral memory.  36:357-358. 2011

Insulin regulation of monoamine signaling: Pathway to obesity.  36:359-360. 2011

Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.  35:2110-2119. 2010

Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.  35:1761-1774. 2010

Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.  35:632-640. 2010

Modulation of limbic circuitry predicts treatment response to antipsychotic medication: A functional imaging study in schizophrenia.  34:2675-2690. 2009

Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects.  33:2324-2340. 2008

Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.  33:2175-2186. 2008

Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.  33:1760-1772. 2008

Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects.  32:2338-2350. 2007

High-dose methadone maintenance in rats: Effects on cocaine self-administration and behavioral side effects.  32:2290-2300. 2007

Reply: 'Second generation antipsychotic drugs: Is there a common mechanism in the development of obesity?' [2].  32:2433-2434. 2007

Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.  32:1888-1902. 2007

Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis.  32:765-772. 2007

Reply to Balcar and Nanitsos. Reply: Autoradiography of [ ³H]aspartate and glutamate transport in schizophrenia [2].  31:687-688. 2006

Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia.  31:221-230. 2006

Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia.  30:2275-2282. 2005

Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement.  30:1681-1692. 2005

Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims.  30:1548-1556. 2005

Cortical glutamatergic markers in schizophrenia.  30:1521-1531. 2005

Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors.  30:1443-1454. 2005

Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: Role in LH behavior.  30:473-483. 2005

Gene expression changes induced by repeated cocaine administration through the dopamine D1 receptors.  30:1443-1454. 2005

Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signalling in fibroblasts from melancholic deppresed patients.  29:2081-2087. 2004

Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder.  29:1353-1362. 2004

Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use.  29:1312-1320. 2004

Gender-Specific Gene Expression in Post-Mortem Human Brain: Localization to Sex Chromosomes.  29:373-384. 2004

Differential Expression of Pentraxin 3 in Fibroblasts from Patients with Major Depression.  29:126-132. 2004

7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.  28:100-107. 2003

Erratum: mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims (Neuropsychopharmacology (October 2002) 27:4 (499-517) PII:S0893133X02003354).  27:1092. 2002

mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims.  27:499-517. 2002

Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.  26:301-310. 2002

Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder.  26:368-375. 2002

Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients.  26:216-228. 2002

Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.  24:545-552. 2001

Ketamine effects on eye movements.  23:645-653. 2000

New initiative: Neuropsychopharmacology online rapid publication.  23:221-222. 2000

Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain.  21:341-351. 1999

Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.  21:195-202. 1999

AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics.  19:278-286. 1998

Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells.  17:12-17. 1997

Linking the family of D2 receptors to neuronal circuits in human brain: Insights into schizophrenia.  16:375-384. 1997

Dopamine receptor mRNA expression in human striatum and neocortex.  15:17-29. 1996

β-Adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression.  15:555-561. 1996

Dopamine receptor gene expression in the human medial temporal lobe.  10:239-248. 1994

Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in the rat brain.  5:231-242. 1991